John L Johnson

A metabolic biosignature of early response to anti-tuberculosis treatment

Gerhard Walzl, John L. Johnson, Gilla Kaplan, 2014, BMC Infectious Diseases.

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

Charles M Heilig, Dick Menzies, John L. Johnson, 2009, American journal of respiratory and critical care medicine.